Wikipedia - Peripheral vascular disease

Peripheral vascular disease
Classification and external resources
ICD-10 I73.9
ICD-9 443.9
DiseasesDB 31142
eMedicine med/391 emerg/862
MeSH D016491

Peripheral vascular disease (PVD), also known as peripheral artery disease (PAD) or peripheral artery occlusive disease (PAOD), includes all diseases caused by the obstruction of large arteries in the arms and legs; and it also includes a subset of diseases classified as microvascular diseases resulting from episodal narrowing of the arteries(raynauds), or widening thereof(erythromelalgia) i.e. vascular spasms. PVD can result from atherosclerosis, inflammatory processes leading to stenosis, an embolism, or thrombus formation. It causes either acute or chronic ischemia (lack of blood supply), typically of the legs.

Contents

[edit] Classification

Peripheral artery occlusive disease is commonly divided in the Fontaine stages, introduced by Dr René Fontaine in 1954:[1] 1) mild pain when walking ("claudication"); 2) severe pain when walking relatively shorter distances (intermittent claudication); 3) pain while resting (rest pain); 4) biological tissue loss (gangrene);

[edit] Symptoms

  • Claudication - pain, weakness, numbness, or cramping in muscles due to decreased blood flow
  • Sores, wounds, or ulcers that heal slowly or not at all
  • Noticeable change in color (blueness or paleness) or temperature (coolness) when compared to the other limb
  • Diminished hair and nail growth on affected limb and digits.

[edit] Causes

  • Smoking - tobacco use in any form is the single most important modifiable cause of PVD internationally. Smokers have up to a tenfold increase in relative risk for PVD in a dose-related effect. Exposure to second-hand smoke from environmental exposure has also been shown to promote changes in blood vessel lining (endothelium) which is a precursor to atherosclerosis.
  • Diabetes mellitus - between two and four times increased risk of PVD by causing endothelial and smooth muscle cell dysfunction in peripheral arteries. Diabetics account for up to 70% of nontraumatic amputations performed, and a known diabetic who smokes runs an approximately 30% risk of amputation within 5 years.
  • Dyslipidemia - elevation of total cholesterol, LDL cholesterol, and triglyceride levels each have been correlated with accelerated PVD. Correction of dyslipidemia by diet and/or medication is associated with a major improvement in short-term rates of heart attack and stroke. This benefit is gained even though current evidence does not demonstrate a major reversal of peripheral and/or coronary atherosclerosis.
  • Hypertension - elevated blood pressure is correlated with an increase in the risk of developing PVD, as well as in associated coronary and cerebrovascular events (heart attack and stroke).
  • Other risk factors which are being studied include levels of various inflammatory mediators such as C-reactive protein, homocysteine, and an over active sex life may increase risk of contracting PVD

[edit] Diagnosis

Upon suspicion of PVD, the first-line study is the ankle brachial pressure index (ABPI/ABI) which is a measure of the fall in blood pressure in the arteries supplying the legs. A reduced ABPI (less than 0.9) is consistent with PVD. Values of ABPI below 0.8 indicate moderate disease and below 0.5 severe disease.ABPI less than 0.3 signifies "critical limb ischemia" where emergency measures are needed to save the limb. It is possible for conditions which stiffen the vessel walls (such as calcifications that occur in the setting of chronic diabetes) to produce incorrect readings and high values(>1.3), meriting further investigation regardless.

If ABPI's are abnormal the next step is generally a lower limb doppler ultrasound examination to look at site and extent of atherosclerosis at the femoral artery. Other imaging can be performed by angiography, where a catheter is inserted into the femoral artery and selectively guided to the artery in question and then used to inject radiodense contrast agent whilst an X-ray is taken. Any stenosis of the arteries can be identified and treated at the same time by balloon angioplasty if the stenosis is over a short segment (<3 cm). However if the artery is occluded or there is diffuse disease present, then arterial bypass surgery may be required.

Modern multislice computerized tomography (CT) scanners provide direct imaging of the arterial system as an alternative to angiography. CT provides complete evaluation of the aorta and lower limb arteries without the need for an angiogram's arterial injection of contrast agent.

[edit] Prevalence and Incidence

The prevalence of peripheral vascular disease in people aged over 55 years is 10%–25% and increases with age; 70%–80% of affected individuals are asymptomatic; only a minority ever require revascularisation or amputation[2]. Peripheral vascular disease affects 1 in 3 diabetics over the age of 50.[3]

In the USA peripheral arterial disease affects 12–20 percent of Americans age 65 and older. Approximately 10 million Americans have PVD. Despite its prevalence and cardiovascular risk implications, only 25 percent of PAD patients are undergoing treatment.[4]

The incidence of symptomatic PVD increases with age, from about 0.3% per year for men aged 40–55 years to about 1% per year for men aged over 75 years. The prevalence of PVD varies considerably depending on how PAD is defined, and the age of the population being studied.[2] Diagnosis is critical, as people with PAD have a four to five times higher risk of heart attack or stroke.

In Western Australia, the prevalence of symptomatic disease at around 60 years of age is about 5%.[5]

A study from the NHANES 1999–2000 data found that PVD affects approximately 5 million adults.[4]

The Diabetes Control and Complications Trial and U.K. Prospective Diabetes Study trials in people with type 1 and type 2 diabetes, respectively, demonstrated that glycemic control is more strongly associated with microvascular disease than macrovascular disease. It may be that pathologic changes occurring in small vessels are more sensitive to chronically elevated glucose levels than is atherosclerosis occurring in larger arteries.[6]

[edit] Therapy

Dependent on the severity of the disease, the following steps can be taken:

  • Conservative measures include Smoking cessation (cigarettes promote PVD and are a risk factor for cardiovascular disease). Regular exercise for those with claudication helps open up alternative small vessels (collateral flow) and the limitation in walking often improves. Medication with aspirin, clopidogrel and statins, which reduce clot formation and cholesterol levels, respectively, can help with disease progression and address the other cardiovascular risks that the patient is likely to have.[7] Treadmill exercise has been reviewed as another treatment with a number of positive outcomes including reduction in cardiovascular events and improved quality of life [8]
  • Angioplasty (PTA or percutaneous transluminal angioplasty) can be done on solitary lesions in large arteries, such as the femoral artery.
  • Plaque excision, in which the plaque is scraped off of the inside of the vessel wall.
  • Occasionally, bypass grafting is needed to circumvent a seriously stenosed area of the arterial vasculature. Generally, the saphenous vein is used, although artificial (Gore-Tex) material is often used for large tracts when the veins are of lesser quality.
  • Rarely, sympathectomy is used - removing the nerves that make arteries contract, effectively leading to vasodilatation.
  • When gangrene of toes has set in, amputation is often a last resort to stop infected dying tissues from causing septicemia.
  • Arterial thrombosis or embolism has a dismal prognosis, but is occasionally treated successfully with thrombolysis.

[edit] Associations

Many PVD patients also have angina pectoris or have had myocardial infarction. There is also an increased risk for stroke.

The moderate consumption of alcohol has been found to be associated with a reduction of the risk of PVD by almost one-third compared to those who do not drink alcohol.[9]

[edit] Guidelines

Several different guideline standards have been developed, including:

  • ACC/AHA Guidelines[13]

[edit] See also

[edit] References

  1. ^ Fontaine R, Kim M, Kieny R (1954). "Die chirugische Behandlung der peripheren Durchblutungsstörungen. (Surgical treatment of peripheral circulation disorders)" (in German). Helvetica Chirurgica Acta 21 (5/6): 499–533. PMID 14366554. 
  2. ^ a b "Peripheral arterial disease prevention and prevalence". Peripheral Arterial Disease. Your Health Encyclopedia. Nov 1 2007. http://www.3-rx.com/ab/more/peripheral-arterial-disease-prevention-and-prevalence/. Retrieved 2007-12-03. 
  3. ^ "Diabetes and peripheral arterial disease". http://www.diabetes.co.uk/diabetes-complications/peripheral-arterial-disease.html. 
  4. ^ a b A. Richey Sharrett, MD, DRPH (Sep 21 2007). "Peripheral arterial disease prevalence". Peripheral Arterial Disease. Armenian Health Network, Health.am. http://www.health.am/vein/more/peripheral-arterial-disease-prevalence/. Retrieved 2007-12-03. 
  5. ^ Hiatt W, Hoag S, Hamman R. (Sep 21 1995). "Effect of diagnostic criteria on the prevalence of peripheral arterial disease". Effect of diagnostic criteria on the prevalence of peripheral arterial disease. Circulation 1995; 91: 1472-1479. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7867189&dopt=Abstract. Retrieved 2007-12-03. 
  6. ^ Elizabeth Selvin, PHD, MPH, Keattiyoat Wattanakit, MD, MPH, Michael W. Steffes, MD, PHD, Josef Coresh, MD, PHD and A. Richey Sharrett, MD, DRPH (Oct 20 2005). "HbA1c and Peripheral Arterial Disease in Diabetes". The Atherosclerosis Risk in Communities study. Diabetes Care. http://care.diabetesjournals.org/cgi/content/full/29/4/877. Retrieved 2007-12-03. 
  7. ^ Diseases Mount Sinai Hospital, New York
  8. ^ [1]Treadmill Exercise and Resistance Training in Patients With Peripheral Arterial Disease With and Without Intermittent Claudication. JAMA. 2009;301(2):165-174.
  9. ^ Camargo CA, Stampfer MJ, Glynn RJ, et al. (4 February 1997). "Prospective study of moderate alcohol consumption and risk of peripheral arterial disease in US male physicians". Circulation 95 (3): 577–80. PMID 9024142. http://circ.ahajournals.org/cgi/content/full/95/3/577. 
  10. ^ Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J; TASC II Working Group. (2007). "Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)". Eur J Vasc Endovasc Surg. 33 (Suppl 1): S1–75. doi:10.1016/j.ejvs.2006.09.024. PMID 17140820. http://www.tasc-2-pad.org/. 
  11. ^ Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J; TASC II Working Group. (2007). "Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)". J Vasc Surg. 45 (Suppl S): S5–67. doi:10.1016/j.jvs.2006.12.037. PMID 17223489. http://www.tasc-2-pad.org/. 
  12. ^ Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J; TASC II Working Group. (2007). "Inter-Society Consensus for the Management of Peripheral Arterial Disease". Int Angiol. 26 (2): 81–157. PMID 17489079. http://www.tasc-2-pad.org/. 
  13. ^ Hirsch AT, Haskal ZJ, Hertzer NR, et al. (2006). "ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation". J. Am. Coll. Cardiol. 47 (6): 1239–312. doi:10.1016/j.jacc.2005.10.009. PMID 16545667. http://www.guideline.gov/summary/summary.aspx?doc_id=8503&nbr=4740. 

[edit] External links


This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Peripheral vascular disease".

Need A Plavix Attorney?

First Name Last Name Email Address State
Has Your Health Been Negatively Affected?

Please Describe the Injury

Your Friend's Email Address

Your Email Address

Type a Message (optional)


 

Close (x)

Looking for an Attorney?


Please type your question:

Close (x)

logo Find Legal Help for Your Plavix Case - Submit Your Information Below

Do you need legal assistance with your Plavix case?
LegalView may be able to help.


Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *
Last name *
Email Address *
Phone Number *
()  -

State *
Legal Issue * DrugWatch: Plavix Change
Was There an Injury?
Please Describe The Injury

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website [more...]

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.